Fideliomed Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 15

Fideliomed General Information

Description

Developer of an AI-driven diagnostic platform designed for real-time risk prediction. The company offers end-to-end AI-driven diagnostics, real-time point-of-need testing, proactive at-risk patient identification, a unified care pathway platform, seamless specialist access integration, and disease-oriented diagnostic analysis, enabling healthcare providers to deliver efficient disease care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Fieno 8
  • Milan
  • Italy
+39 339
Primary Industry
Decision/Risk Analysis
Corporate Office
  • Via Fieno 8
  • Milan
  • Italy
+39 339

Fideliomed Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fideliomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Early Stage VC 01-Jan-2025 Completed Generating Revenue
12. Accelerator/Incubator 03-Oct-2024 Completed Generating Revenue
11. Accelerator/Incubator 30-Jul-2024 Completed Generating Revenue
10. Angel (individual) 01-Jan-2024 Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Angel (individual) Completed Generating Revenue
6. Grant 18-Sep-2023 Completed Generating Revenue
5. Accelerator/Incubator 08-Sep-2023 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
To view Fideliomed’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Fideliomed Patents

Fideliomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4655582-A1 Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters Active 24-Jan-2023
US-20260227306-A1 Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters Pending 24-Jan-2023
WO-2024157161-A8 Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters Inactive 24-Jan-2023
WO-2024157161-A1 Method and electroanalytical sensor for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haemotological parameters Inactive 24-Jan-2023
EP-4655582-B1 Method for detecting and/or quantifying, in a sample of blood or derivate biological liquid, a panel of haematological parameters Active 24-Jan-2023 G01N15/0656
To view Fideliomed’s complete patent history, request access »

Fideliomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fideliomed Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
20 Fund Venture Capital Minority
Fondazione Social Venture Impact Investing Minority
Rigel Ventures Venture Capital Minority
Jumpstart Ventures Venture Capital Minority
Get it! Accelerator/Incubator
You’re viewing 5 of 15 investors. Get the full list »

Fideliomed FAQs

  • When was Fideliomed founded?

    Fideliomed was founded in 2022.

  • Where is Fideliomed headquartered?

    Fideliomed is headquartered in Milan, Italy.

  • What is the size of Fideliomed?

    Fideliomed has 3 total employees.

  • What industry is Fideliomed in?

    Fideliomed’s primary industry is Decision/Risk Analysis.

  • Is Fideliomed a private or public company?

    Fideliomed is a Private company.

  • What is Fideliomed’s current revenue?

    The current revenue for Fideliomed is .

  • Who are Fideliomed’s investors?

    20 Fund, Fondazione Social Venture, Rigel Ventures, Jumpstart Ventures, and Get it! are 5 of 15 investors who have invested in Fideliomed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process